• Tidak ada hasil yang ditemukan

COST-EFFECTIVENESS ANALYSIS OF PHARMACOTHERAPY FOR HEMATEMESIS-MELENA TREATMENT IN HOSPITALIZED PATIENT WITH HEPATIC CIRRHOSIS - Ubaya Repository

N/A
N/A
Protected

Academic year: 2017

Membagikan "COST-EFFECTIVENESS ANALYSIS OF PHARMACOTHERAPY FOR HEMATEMESIS-MELENA TREATMENT IN HOSPITALIZED PATIENT WITH HEPATIC CIRRHOSIS - Ubaya Repository"

Copied!
10
0
0

Teks penuh

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)

Referensi

Dokumen terkait

Berdasarkan perhitungan ICER (Incremental Cost-Effectiveness Ratio) pengobatan pasien pasca seksio sesarea rawat inap dengan menggunakan antibiotik profilaksis dan terapi bentuk

Oleh karena besarnya biaya pengobatan jangka panjang sirosis hepatik yang harus ditanggung, maka diperlukan suatu penelitian untuk menganalisa terapi sirosis

This occur to appear a great concern of drug interactions as known to be related to adverse drug reactions and hospitalization, therefore a study to analyze

Karya Ilmiah disajikan dalam: The 1st International Pharmacy Conference on Research and Practice November 2012, Yogyakarta DRUG INTERACTION ANALYSIS IN HOSPITALIZED AND

CONCLUSSION As aspirin give shorter Length of Stay, better Health Status based on NIHSS score and less costly, we conclude that aspirin is cost effective compared to citicoline in

38 used to estimate costs and outcomes of infliximab and conventional treatment including Patient’s weight, probability of achieving remission, clinical response, and surgery for each

International Conference on Applied Science and Health 2017 Improving health and well-being for better society 128 ICASH-A23 COST EFFECTIVENESS AND EFFICIENCY ANALYSIS OF